Cinnamaldehyde ethylene glycol acetal
Common Name: |
Cinnamaldehyde ethylene glycol acetal |
IUPAC Name: |
2-[(E)-2-phenylethenyl]-1,3-dioxolane |
Molecular Formula: |
C11H12O2 |
SMILES: |
C1COC(O1)C=CC2=CC=CC=C2 |
Inchi: |
1S/C11H12O2/c1-2-4-10(5-3-1)6-7-11-12-8-9-13-11/h1-7,11H,8-9H2/b7-6+ |
Inchi Key: |
JQLASNFFJHGQTK-VOTSOKGWSA-N |
Cas No: |
5660-60-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
176.21 |
Mass (g/mol) |
176.084 |
Molar Refractivity |
51.01 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
2 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
265.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.014 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.27 |
LogP |
2.073 |
iLOGP |
2.51 |
XLOGP3 |
1.97 |
WLOGP |
1.96 |
MLOGP |
1.78 |
ESOL Log S |
-2.38 |
ESOL Solubility (mg/ml) |
0.729 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-1.98 |
Ali Solubility (mg/ml) |
1.83 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.56 |
Silicos-IT Solubility (mg/ml) |
0.48 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.98 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.576 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.292 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |